Routine admission screening of patients is desirable, but financial and personnel support for diabetes services is essential
Hyperglycaemia is common among hospitalised patients and is associated with increased complication rates, longer admissions, more frequent re‐admissions, and higher mortality.1,2,3,4 Its detection can also be an opportunity for identifying undiagnosed diabetes. Trials have confirmed that improving inpatient glycaemic control reduces complication rates,2 and guidelines recommend that the blood glucose levels of all patients be checked on admission; if hyperglycaemia is detected, glycated haemoglobin (HbA1c) should also be measured.2,5 HbA1c assessment can help differentiate stress‐induced hyperglycaemia from undiagnosed diabetes, and also aids evaluation of treatment adequacy in people with known diabetes. Nevertheless, the identification of undiagnosed diabetes in hospitalised patients is sub‐optimal.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Jonathan Shaw is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship. This work was partly supported by the Victorian Operational Infrastructure Support Program. Matthew Hare is supported by an NHMRC Postgraduate Scholarship, the Australian Academy of Science Douglas and Lola Douglas Scholarship, and the NHMRC/Diabetes Australia Postgraduate Award.
Jonathan Shaw has received honoraria for lectures and consultancies from Astra Zeneca, Eli Lilly, Mylan, Novo Nordisk, Sanofi, Merck Sharp and Dohme, Abbott, and Boehringer Ingelheim.